Ponoi Capital II, LP, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 4,387 shares at $11.86 ($52K) on 2019-10-23, disclosed to the SEC on 2019-10-24.
Open-market purchase of $52k NGM by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.00 | 2,300 | $28K | 52.7% |
| 2 | $11.86 | 2,087 | $25K | 47.3% |
| Total | $11.93 avg | 4,387 | $52K | 100% |
| Filing → |
| NGM | BUY | 2022-10-27 | $1.2M | — | Filing → |
| NGM | BUY | 2022-05-17 | $842K | — | Filing → |
| RAPT | SELL | 2021-09-29 | $578K | — | Filing → |